Professor Marco Falasca
Curtin University, Perth
Marco Falasca had his formal training in pharmacology and Pharmaceutical Chemistry with research experience in cell biology (signal transduction) and cancer pharmacology (enzymology). He received the Ph.D.eq degree from the Istituto Mario Negri Sud, in 1985 and 1994, respectively. From 1995 to 1997, M. Falasca was a Postdoctoral of the Department of Pharmacology at New York University. From 1998 to 2000 he was group leader at Consorzio Mario Negri Sud, Italy. From 2001 to 2007 M. Falasca was appointed as a Principal Research Fellow at University College London, Department of Medicine. From 2007 to 2014 he was appointed as a Professor at the Blizard Institute, Queen Mary University of London. In 2014, he was recruited by Curtin University, Perth, Australia, to establish a Metabolic Signalling group and held a Chair in Metabolism. The focus of his research in the past 30 years involved the investigation of deregulation of lipid metabolism in cancer biology. His work is mostly focused on identification of novel theranostic strategies for pancreatic cancer.